Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke.

@article{Smith2011OutcomesIM,
  title={Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke.},
  author={Eric E Smith and Gregg C Fonarow and Mathew J Reeves and Margueritte Cox and DaiWai M Olson and Adrian F. Hernandez and Lee H Schwamm},
  journal={Stroke},
  year={2011},
  volume={42 11},
  pages={3110-5}
}
BACKGROUND AND PURPOSE Mild or rapidly improving stroke is a frequently cited reason for not giving intravenous recombinant tissue-type plasminogen activator (rtPA), but some of these patients may have poor outcomes. We used data from a large nationwide study (Get With The Guidelines-Stroke) to determine risk factors for poor outcomes after mild or improving stroke at hospital discharge. METHODS Between 2003 and 2009, there were 29,200 ischemic stroke patients (from 1092 hospitals) arriving… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
60 Citations
13 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 60 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 13 references

Priori - tizing interventions to improve rates of thrombolysis for ischemic stroke

  • D Kleindorfer, B Kissela, A Schneider, D Woo, J Khoury, R Miller
  • Neurology
  • 2005

: a population - based study

  • EE Smith, AR Abdullah, I Petkovska, E Rosenthal, WJ Koroshetz, LH Schwamm
  • 2004

Similar Papers

Loading similar papers…